Dr. Aimaz Afrough, MD

Dr. Afrough practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Afrough's NPI, 1477964518, was assigned on May 12, 2014. Dr. Afrough graduated from Tabriz University of Medical Sciences in 2008. Dr. Afrough holds Texas license R2795.

Dr. Afrough's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Afrough's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afrough practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Afrough's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Afrough is board certified in hematology by the American Board of Internal Medicine. Dr. Afrough is licensed in Texas.

Dmand AI lists chronic anemia, lymphoma and multiple myeloma among the conditions Dr. Afrough treats.

CMS data shows 511 Medicare services from Dr. Afrough across 7 procedure codes in 2024, for 240 Medicare patients. Medicare paid $49,580 for them.

CMS counts 240 Medicare patients who saw Dr. Afrough in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Afrough's median patient age at 69, with 52% women.

In 2024, Dr. Afrough wrote 814 Medicare Part D claims for 116 patients. 78% of them were for generic drugs. CMS names the drug for 693 of them, across 18 drugs with 11 or more claims each, at $3,860,130 in total drug cost. In 2023, CMS named 742 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Afrough for performance year 2024, reported as part of a group. Dr. Afrough accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Afrough as offering telehealth.

Dmand AI links 35 papers to Dr. Afrough, published from 2011 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Immunotherapy, Adoptive. Dr. Afrough has published most often in Biol Blood Marrow Transplant. Dr. Afrough's most frequent co-authors are Larry D. Anderson, MD, PhD, Muzaffar H. Qazilbash, MD and Richard E. Champlin, MD.

CMS Open Payments shows 202 general payments to Dr. Afrough from 30 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 54% of the total. Janssen Pharmaceuticals, Inc paid the most, $4,306.

Dr. Afrough graduated from Tabriz University of Medical Sciences in 2008. Dr. Afrough is a member of ASCO.

Dr. Afrough is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.